Adalimumab for refractory peripheral ulcerative keratitis.

about

Biologic therapy for refractory scleritis: a new treatment perspective.Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.

P2860

Q38576234-C8D46235-FEA5-485D-98F7-A6AF4AB92AA3 Q41146632-D91DD39A-517F-4C8F-B705-333CE72ABBCB

P2860

Adalimumab for refractory peripheral ulcerative keratitis.

Item

http://www.wikidata.org/entity/Q41457317

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Adalimumab for refractory peripheral ulcerative keratitis.

@en

type

Item

label

Adalimumab for refractory peripheral ulcerative keratitis.

@en

prefLabel

Adalimumab for refractory peripheral ulcerative keratitis.

@en

P1476

Adalimumab for refractory peripheral ulcerative keratitis.

@en

P2093

Alvaro Casado Blanco

http://www.w3.org/2001/XMLSchema#string

Ana López Corral

http://www.w3.org/2001/XMLSchema#string

José M Ruiz de Morales

http://www.w3.org/2001/XMLSchema#string

Miguel Cordero-Coma

http://www.w3.org/2001/XMLSchema#string

Raquel Salazar Méndez

http://www.w3.org/2001/XMLSchema#string

Sara Calleja-Antolín

http://www.w3.org/2001/XMLSchema#string

P2860

Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations

Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab.

Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.

Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis.

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

P2888

s12348-012-0080-z

P304

227-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S12348-012-0080-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224966054

http://www.w3.org/2001/XMLSchema#string

P698

22588776

http://www.w3.org/2001/XMLSchema#string

P921

adalimumab

P932

3500990

http://www.w3.org/2001/XMLSchema#string

Adalimumab for refractory peripheral ulcerative keratitis.

about

P2860

P2860

Adalimumab for refractory peripheral ulcerative keratitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932